New approach needed to tackle emerging zoonotic diseases

(Medical Xpress)—A more coordinated approach to surveillance is required if emerging diseases which can spread from animals to humans are to be tackled, say scientists.

Around 75 per cent of all recently are infections that can be transmitted between animals and humans, which are known as zoonoses. Many of these diseases are first observed causing disease in animals, for example Virus in great apes, in crows, and in livestock.

Writing in Philosophical Transactions B of The Royal Society, researchers at the University of Glasgow are calling for a shift in focus of surveillance for zoonoses to build systems that tackle both emerging and endemic zoonoses in developing countries.

This, they argue, will overcome barriers to the reporting of emerging diseases and also help alleviate the burden of endemic diseases, that have huge impacts upon the health and livelihoods of impoverished communities throughout the developing world.

Lead researcher Dr Jo Halliday from the Institute of Biodiversity, Animal Health and , said: "Early detection of in human and is crucial to the effective surveillance of emerging diseases. At the moment though, there are several barriers to disease reporting and surveillance that limit the effectiveness of and control efforts and the impacts of these barriers are most severe in the ."

Dr Halliday said: "Because of the potential for rapid international spread of , this reduced capacity for early detection of disease outbreaks in many developing regions has implications for the global community as a whole."

To overcome these problems, the researchers propose the development of 'linked strategies' that simultaneously tackle the important public health problems posed by endemic zoonoses in developing countries as well as building capacity that can help detect and control future disease threats.

Dr Halliday added: "It is important to focus efforts and investments on building core capacities that are common to many surveillance systems and inherently adaptable. While a lot of investment has gone into the technical aspect of surveillance – such as laboratory equipment and communication infrastructures – there is a need to recognise the constraints to reporting at the grassroots level.

"Animal and human health workers are the primary source of surveillance data and it is important to understand their ability and willingness to report disease outbreaks.

"Building systems that tackle existing disease problems can help to build the core capacities required for successful surveillance of all zoonotic diseases and also identify appropriate mechanisms for incentivising reporting to build sustainable systems.

"Mobile phone technology has enormous potential for improving health systems, including surveillance. Massive increases in network coverage, handset ownership and therefore familiarity with the technology mean that mobile phones hold particular promise in areas that are currently least well served by existing systems. A key strength is that they can be used to provide feedback, information and advice that can help to incentivize reporting.

"Future investments should also build upon a much greater understanding of why individuals choose to act and report disease, rather than focusing exclusively on technology of the tools used. Simply put, effective surveillance on the global scale is only feasible if individuals want to contribute and are not disadvantaged by reporting.

"Incentives could include remuneration, meeting performance contracts, reinforcement of social standing by triggering an effective response and a global fund to financially compensate countries that report outbreaks."

The researchers argue that many endemic zoonoses are prime areas for investment in disease control measures and that many surveillance systems that were set up to deal with specific pathogens – such as polio or influenza – have now expanded their surveillance efforts to other diseases.

Dr Halliday said: "Investment in the surveillance of endemic zoonotic pathogens provides a mechanism for building exactly the core capacities that are likely to enable the detection of emerging infections.

"This is a more equitable and sustainable mechanism for building the culture of surveillance and the core capacities that are needed for all zoonotic pathogens, including emerging disease threats."

add to favorites email to friend print save as pdf

Related Stories

IOM report released on species-jumping diseases

Sep 22, 2009

Significant weaknesses undermine the global community's abilities to prevent, detect early, and respond efficiently to potentially deadly species-crossing microbes, such as the pandemic H1N1 influenza virus sweeping the globe, ...

Protecting humans and animals from diseases in wildlife

Oct 07, 2009

Avian influenza (H5N1), rabies, plague, Bovine Spongiform Encephalopathy (BSE), and more recently swine flu (H1N1) are all examples of diseases that have made the leap from animals to humans. As the list continues to grow, ...

Recommended for you

New hope for rare disease drug development

1 hour ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

4 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

5 hours ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

Anti-diabetic drug springs new hope for tuberculosis patients

11 hours ago

A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.